Halliburton (HAL) Earnings Analysis
Halliburton (HAL) next reports earnings on 2026-10-20, consensus EPS 0.6 USD. Last quarter (2026-07-21) it beat with EPS 0.55 USD vs 0.538 USD est (+2.2%). It has beaten estimates in 3/6 recent quarters (50%). Trailing P/E 18.14.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does HAL next report earnings?
| Next earnings date | 2026-10-20 |
|---|---|
| Consensus EPS estimate | 0.6 USD |
| Revenue estimate | 5.60B |
HAL earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-07-21 | 0.55 USD | 0.538 USD | +2.2% | Beat |
| 2026-01-21 | 0.69 USD | 0.551 USD | +25.2% | Beat |
| 2025-10-21 | 0.58 USD | 0.4987 USD | +16.3% | Beat |
| 2025-07-22 | 0.55 USD | 0.552 USD | -0.4% | Miss |
| 2025-01-22 | 0.7 USD | 0.73 USD | -4.1% | Miss |
| 2024-11-07 | 0.73 USD | 0.75 USD | -2.7% | Miss |
Beat rate: 3/6 (50%) over reported quarters with consensus data.
HAL valuation and analyst view
| Trailing P/E | 18.14 |
|---|---|
| Trailing EPS | 1.84 USD |
| Price / book | 2.55 |
| Dividend yield | 2.06% |
| Market cap | 27.39B |
| Analyst consensus | Buy (47 buy / 15 hold / 2 sell) |
| Avg price target | 44.1 USD |
Related research pages
Frequently asked questions
When is Halliburton (HAL)'s next earnings date?
Halliburton is next scheduled to report on 2026-10-20, with a consensus EPS estimate of 0.6 USD and revenue estimate of 5.60B.
Did HAL beat earnings last quarter?
In its 2026-07-21 report, HAL posted EPS of 0.55 USD versus a 0.538 USD estimate — a beat of 2.2%.
What is HAL's earnings track record?
Over the last 6 reported quarters with consensus data, HAL beat estimates 3 times (50%).
What is HAL's current P/E ratio and EPS?
HAL trades at a trailing P/E of 18.14 on trailing EPS of 1.8399044205495818 USD.
What do analysts rate HAL?
Analyst consensus is "Buy" across 64 ratings (1 strong buy, 46 buy, 15 hold, 2 sell, 0 strong sell). Average 12-month price target: 44.1 USD.